Vnta Walking Club Walker of the Week: Nancy With grocery prices soaring, coupons can be a big money saver. But many shoppers these days are now having trouble accessing supermarket coupons because more and more of them now require a smartphone.And some consumer advocates are calling the practice discriminatory.Seniors struggle to get the advertised dealPat O Brien is a Senior living on Social Security who is getting frustrated trying to save money on groceries during these inflationary times. They are making it too ha [url=https://www.stanley-mugs.us]stanley mugs[/url] rd, she said. I mean, seriously. Like millio [url=https://www.stanley-cups.es]vaso stanley[/url] ns of seniors, she struggles with her smartphone and has been unable to access digital coupons that could give her a dollar off on some items. As a result, O Brien [url=https://www.stanleycups.at]stanley becher[/url] says she is forced to pay the full list price.Tina Hern, meantime, is an elder caregiver and says the move away from paper coupons is hurting many of her older, lower-income clients. I am actually a personal care assistant, Hern said, and I shop for my older clients because it is so hard and complicated for them to understand. The report claims many shoppers are at a disadvantageA new report from ConsumerWorld.org finds many of the biggest sales are now digital-only, according to site founder and consumer advocate Edgar Dworsky. We found these issues with shrimp and chicken breast, so it wasn t just a can of coffee we are talking about, Dworsky said.Dworsky says digital-only coupons put thousands, if not millions, of shoppers at a disadvantage. Anyone who s not connected today is missing out on su Kzmu NASA s Mars rover collects first rock sample A company that is partnering with the National Institutes of Health to develop a vaccine for the novel coronavirus reported encouraging results Monday from its Phase 1 human trial.In a press release, Moderna says that after testing the vaccine in eight subjects at both low and medium dosage, all test subjects have antibodies in their bloodstream that could fight off the coronavirus.Three patients who received a higher dosage reported systemic symptoms in connection with the vaccine, but Moderna says all side effects have been transient and self-resolving, and none were serious.Moderna said during its Phase 2 trial will focus on two dosage levels. Results from those tests will inform the dosage for a large-scale Phase 3 trial, tentatively scheduled to begin in June. With todays positive interim Phase 1 data and the positive data in the mouse challenge model, the Moderna team continues to focus on moving as fast as safely possible to start o [url=https://www.stanley-cup.ca]stanley canada[/url] ur pivotal Phase 3 study in July and, i [url=https://www.cups-stanley.us]cups stanley[/url] f successful, file a BLA, St茅phane Bancel, Moderna s CEO said in a press release. We are investing to scale up manufacturing so we can maximize the number of doses we can produce to help protect as many people as we can from SARS-CoV-2. Though the vaccine has only been tested on a microscopic scale, it o [url=https://www.stanleycups.com.mx]stanley en mexico[/url] ffers a promising milestone in the White House s ambitious plan to develop a viable coronavir